• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较 COVID-19 大流行前和大流行期间 ST 段抬高型心肌梗死患者的长期预后。

Comparison of long-term outcome of patients with ST-segment elevation myocardial infarction between pre-COVID-19 and COVID-19 era.

机构信息

Department of Cardiology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey.

Department of Cardiology, Balikesir University Medical School, Balikesir, Turkey.

出版信息

Eur J Clin Invest. 2022 Oct;52(10):e13834. doi: 10.1111/eci.13834. Epub 2022 Aug 8.

DOI:10.1111/eci.13834
PMID:35851657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9349930/
Abstract

AIMS

To compare major cardiovascular and cerebrovascular events (MACCE) rates between patients in the pre-COVID-19 era and COVID-19 era, and to assess the impact of the presence of COVID-19 (+) on long-term MACCE in ST-segment elevation myocardial infarction (STEMI) in Turkey.

METHODS

Using the TURSER study (TURKISH ST-segment elevation myocardial infarction registry) data, the current study included 1748 STEMI patients from 15 centres in Turkey. Patients were stratified into COVID-19 era (March 11st-May 15st, 2020; n = 723) or pre-COVID-19 era (March 11st-May 15st, 2019; n = 1025) cohorts. Long-term MACCE rates were compared between groups. In addition, the effect of COVID-19 positivity on long-term outcomes was evaluated. The primary outcome was the occurrence of MACCE at long-term follow-up, and the secondary outcome was hospitalization with heart failure.

RESULTS

The MACCE and hospitalization with heart failure rates between pre-COVID-19 era and COVID-19 era were 23% versus 22% (p = .841), and 12% versus 8% (p = .002), respectively. In the COVID-19 era, the rates of MACCE and hospitalization with heart failure COVID-19-positive versus COVID-19-negative patients were 40% versus 20%, (p < .001), and 43% versus 11% (p < .001), respectively.

CONCLUSION

There was no difference between the pre-COVID-19 era and the COVID-19 era in terms of MACCE  in STEMI patients in Turkey. In the COVID-19 era, STEMI patients positive for COVID-19 had a higher rate of MACCE and heart failure hospitalization at the long-term follow-up.

摘要

目的

比较 COVID-19 前时期和 COVID-19 时期患者的主要心血管和脑血管事件(MACCE)发生率,并评估 COVID-19(+)在土耳其 ST 段抬高型心肌梗死(STEMI)患者中的长期 MACCE 中的影响。

方法

使用 TURSER 研究(土耳其 STEMI 注册研究)的数据,本研究纳入了来自土耳其 15 个中心的 1748 例 STEMI 患者。患者分为 COVID-19 时期(2020 年 3 月 11 日至 5 月 15 日;n=723)或 COVID-19 前时期(2019 年 3 月 11 日至 5 月 15 日;n=1025)队列。比较两组之间的长期 MACCE 发生率。此外,还评估了 COVID-19 阳性对长期结局的影响。主要结局是长期随访时发生 MACCE,次要结局是心力衰竭住院。

结果

COVID-19 前时期和 COVID-19 时期的 MACCE 和心力衰竭住院率分别为 23%和 22%(p=0.841),12%和 8%(p=0.002)。在 COVID-19 时期,COVID-19 阳性和 COVID-19 阴性患者的 MACCE 和心力衰竭住院率分别为 40%和 20%(p<0.001),43%和 11%(p<0.001)。

结论

在土耳其 STEMI 患者中,COVID-19 前时期和 COVID-19 时期的 MACCE 无差异。在 COVID-19 时期,COVID-19 阳性的 STEMI 患者在长期随访时的 MACCE 和心力衰竭住院率更高。

相似文献

1
Comparison of long-term outcome of patients with ST-segment elevation myocardial infarction between pre-COVID-19 and COVID-19 era.比较 COVID-19 大流行前和大流行期间 ST 段抬高型心肌梗死患者的长期预后。
Eur J Clin Invest. 2022 Oct;52(10):e13834. doi: 10.1111/eci.13834. Epub 2022 Aug 8.
2
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).新型冠状病毒肺炎疫情对土耳其 ST 段抬高型心肌梗死(STEMI)患者的影响:TURSER 研究(土耳其 ST 段抬高型心肌梗死注册研究)结果。
J Thromb Thrombolysis. 2022 Feb;53(2):321-334. doi: 10.1007/s11239-021-02487-3. Epub 2021 May 29.
3
Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (from the INTERSTELLAR Registry).韩国急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗的身高与预后的关系(来自星际注册研究)
Am J Cardiol. 2016 Jul 15;118(2):177-82. doi: 10.1016/j.amjcard.2016.04.046. Epub 2016 May 5.
4
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction.替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗 ST 段抬高型心肌梗死患者的疗效比较。
JACC Cardiovasc Interv. 2021 Feb 22;14(4):431-440. doi: 10.1016/j.jcin.2020.11.036.
5
Long-term outcomes in inferior ST-segment elevation myocardial infarction patients with right ventricular myocardial infarction.下壁伴右心室心肌梗死患者的长期预后。
Int J Cardiol. 2022 Mar 15;351:1-7. doi: 10.1016/j.ijcard.2022.01.003. Epub 2022 Jan 5.
6
Stress hyperglycemia ratio: an independent predictor for in-hospital major adverse cardiovascular and cerebrovascular events in patients with st-segment elevation myocardial infarction.应激性高血糖比值:ST 段抬高型心肌梗死患者院内主要不良心血管和脑血管事件的独立预测因子。
BMC Cardiovasc Disord. 2023 Apr 15;23(1):195. doi: 10.1186/s12872-023-03219-6.
7
Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry.中国接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的症状发作至球囊扩张时间、ST段回落情况及院内死亡率:来自中国急性心肌梗死注册研究
Am J Cardiol. 2016 Nov 1;118(9):1334-1339. doi: 10.1016/j.amjcard.2016.07.058. Epub 2016 Aug 13.
8
Clinical impact of complete atrioventricular block in patients with ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死患者完全性房室传导阻滞的临床影响。
Clin Cardiol. 2021 Jan;44(1):91-99. doi: 10.1002/clc.23510. Epub 2020 Nov 12.
9
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry.慢性阻塞性肺疾病对 COVID-19 大流行期间 ST 段抬高型心肌梗死患者短期预后的影响:来自国际多中心 ISACS-STEMI 注册研究的结果。
Respir Res. 2022 Aug 15;23(1):207. doi: 10.1186/s12931-022-02128-0.
10
Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.新型冠状病毒肺炎患者 ST 段抬高型心肌梗死的流行病学和管理:美国心脏协会新型冠状病毒肺炎心血管疾病注册研究报告。
J Am Heart Assoc. 2022 May 3;11(9):e024451. doi: 10.1161/JAHA.121.024451. Epub 2022 Apr 26.

引用本文的文献

1
Clinical characteristics and outcomes of acute myocardial infarction during the COVID-19 pandemic: a multicenter retrospective cohort study in Northern China.新型冠状病毒肺炎大流行期间急性心肌梗死的临床特征及结局:中国北方一项多中心回顾性队列研究
BMC Cardiovasc Disord. 2025 Mar 27;25(1):226. doi: 10.1186/s12872-025-04686-9.
2
Association of Iron Therapy with Mortality in Patients with Acute Myocardial Infarction and Iron Deficiency.铁剂治疗与缺铁性急性心肌梗死患者死亡率的关系。
Cardiovasc Toxicol. 2024 Oct;24(10):1018-1027. doi: 10.1007/s12012-024-09905-x. Epub 2024 Aug 2.
3
Acute Myocardial Infarction during the COVID-19 Pandemic: Long-Term Outcomes and Prognosis-A Systematic Review.2019冠状病毒病大流行期间的急性心肌梗死:长期结局与预后——一项系统评价
Life (Basel). 2024 Jan 31;14(2):202. doi: 10.3390/life14020202.
4
Association of systemic inflammatory response index with ST segment elevation myocardial infarction and degree of coronary stenosis: a cross-sectional study.全身炎症反应指数与 ST 段抬高型心肌梗死及冠状动脉狭窄程度的相关性:一项横断面研究。
BMC Cardiovasc Disord. 2024 Feb 9;24(1):98. doi: 10.1186/s12872-024-03751-z.
5
Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes.超越急性 COVID-19:长期心血管结局综述。
Can J Cardiol. 2023 Jun;39(6):726-740. doi: 10.1016/j.cjca.2023.01.031. Epub 2023 Feb 6.